NSUN2 and hepatocellular carcinoma: Thus, our findings demonstrate a regulatory mechanism involving NSUN2 and its mediation of RNA m5C modification in the progression of human HCC, indicating that this interaction may serve as a prognostic biomarker in HCC patients.